Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about MKKGY

Recent news which mentions MKKGY

WeRide, CRISPR And GeneDx Are Among Top 10 Mid-Cap Gainers Last Week (Feb 10-Feb 14): Are The Others In Your Portfolio?
Tickers AXSM CRSP GDS MKGAF
Tags Market News RXRX Mid Cap
From Benzinga
Germany's Merck In Talks To Buy Cancer Drug Maker SpringWorks Therapeutics
Tickers MKGAF MKKGY NEWS SWTX
Tags Large Cap MKGAF Benzinga
From Benzinga
GSK To Buy US-Based Stomach Cancer Drug Developer For Over $1 Billion
Tickers GSK MKGAF MKKGY NEWS
Tags MKGAF Stories That Matter Large Cap
From Benzinga
Pfizer Clears Required Regulatory Hurdles To Complete $43B Seagen Acquisition
Tickers MKKGY PFE SGEN
Tags Markets Benzinga Biotech
From Benzinga
Merck Germany's Two Pivotal Trials Flunk In Multiple Sclerosis
Tickers MKGAF MKKGY SNY
Tags SNY General Biotech
From Benzinga
Life Sciences Player Repligen's Strategic European Acquisition - What It Means for Investors
Tickers MKGAF MKKGY RGEN
Tags News M&A Health Care
From Benzinga
Merck Germany Reports 5% Decline In Q2 Sales, Expects More Decline In 2023
Tickers MKGAF MKKGY
Tags Market News Guidance MKGAF
From Benzinga
Novo Nordisk's Obesity Drug Saxenda Not Included In WHO's Essential Drug List
Tickers MKGAF MKKGY NVO REGN
Tags Market News RHHBF News
From Benzinga
Abcam Downgrade: Analyst Trims Expectations Amid Activist Investor Engagement and Potential Bid Anticipation
Tickers A ABCM DHR MKGAF
Tags ABCM MKGAF Analyst Ratings
From Benzinga
Analyst Says Nektar Therapeutics' Rezpeg Prioritization Likely to Spark Investor Questions
Tickers LLY MKGAF MKKGY NKTR
Tags MKGAF Analyst Ratings Penny Stocks
From Benzinga
FDA Issues Partial Clinical Hold On Merck Germany's Multiple Sclerosis Study
Tickers MKGAF MKKGY
Tags Benzinga MKKGY Biotech
From Benzinga
Merck Germany Regains Exclusive Global Rights To Cancer Drug From Pfizer
Tickers M MKGAF MKKGY PFE
Tags M Market News Health Care
From Benzinga
Incyte Would Now Compete With Merck, Pfizer As Its Skin Cancer Treatment Scores FDA Accelerated Approval
Tickers INCY MGNX MKGAF MKKGY
Tags FDA Biotech Benzinga
From Benzinga
With Upcoming Ovarian Cancer Data, Analyst Sees 100% Upside For Mersana Therapeutics
Tickers MKKGY MRSN
Tags Health Care Initiation News
From Benzinga
PDS Biotech, Merck Germany Enter Licensing Pact For Investigational Cancer Treatment
Tickers MKGAF MKKGY PDSB
Tags Biotech Benzinga Small Cap
From Benzinga
Mersana Inks Cancer Therapy Development Deal With Merck Germany
Tickers MKGAF MKKGY MRSN
Tags Market News MKGAF Eurasia
From Benzinga
SpaceX Starlink's New In-Flight Connectivity Service, Amazon's NY Workers Reject Union, Celsius Network Faces Several Federal Investigations: Top Stories Wednesday, Oct. 19
Tickers AAPL ABT ACI AMZN
Tags News TGT META
From Benzinga
Germany's Merck Slapped With Formal French Investigation Related To Its Thyroid Drug
Tickers MKKGY
Tags News Health Care Market News
From Benzinga
PDS Biotech Highlights Expanded Data From PDS0101 Triple Combination Trial In HPV-Positive Cancers
Tickers MKKGY MRK PDSB
Tags PDSB Penny Stocks Trading Ideas
From Benzinga
Here's How Day One Biopharmaceuticals Stock Could Keep Climbing
Tickers DAWN MKKGY
Tags Market News MKKGY ^IXIC
From Motley Fool
Germany's Merck To Launch Semiconductor Base In China
Tickers MKKGY TECH
Tags MKKGY Market News Media
From Benzinga
Wall Street Thinks Palantir Is Poised for a Comeback. Here's Why
Tickers MKKGY PIPR PLTR
Tags PIPR Recent Press Releases PLTR
From Motley Fool
Cathie Wood Can't Get Enough of These 2 Biotech Stocks
Tickers ADPT ARKG BNR MKKGY
Tags BNR MKKGY ARKG
From Motley Fool
TSM Looks To Hire Over 8,000 People In 2022
Tickers ASML ENTG MDTKF MKKGY
Tags Tech Benzinga MDTKF
From Benzinga
Despite Palantir’s Impressive Deals, Its Losses and Valuation Make It Unappetizing
Tickers MKKGY PLTR
Tags Stocks to Sell NYSE:PLTR,OTC:MKKGY MKKGY
From InvestorPlace
The Daily Biotech Pulse: Pfizer Strikes $5.29B COVID Pill Supply Deal With US, Roche's Spark Therapeutics Reports Positive Gene Therapy Readout, EDAP Earnings
Tickers AZN BNR BNTX CBAY
Tags CVAC FDA Biotech
From Benzinga
GlaxoSmithKline, Merck KGaA End $4B Cancer Drug Pact
Tickers GSK MKGAF MKKGY MRK
Tags Health Care lung cancer News
From Benzinga
Nektar, Merck Germany, Pfizer Join Forces For Mid-Stage Bladder Cancer Study
Tickers MKGAF MKKGY NKTR PFE
Tags General Contracts Movers
From Benzinga
Merck KGaA Pulls Plug On GSK-Partnered Cancer Drug Trial
Tickers GSK MKGAF MKKGY MRK
Tags Phase 2 Trial Briefs MKKGY
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.